HAEMONETICS CORP (HAE) › Gross ProfitHAEMONETICS CORP (HAE) — Gross ProfitAnnual figures by fiscal year, from SEC filings.2009: $308.17M2010: $337.48M2011: $355.21M2012: $369.24M2013: $428.13M2014: $468.37M2015: $434.42M2016: $405.91M2017: $378.49M2018: $411.91M2019: $417.54M2020: $484.51M2021: $397.84M2022: $505.50M2023: $615.10M2024: $691.55M2025: $748.96M2026: $787.59M$787.59M2009Gross Profit (USD)2026Fiscal YearGross ProfitChange YoY2026$787.59M+5.2%2025$748.96M+8.3%2024$691.55M+12.4%2023$615.10M+21.7%2022$505.50M+27.1%2021$397.84M-17.9%2020$484.51M+16.0%2019$417.54M+1.4%2018$411.91M+8.8%2017$378.49M-6.8%2016$405.91M-6.6%2015$434.42M-7.2%2014$468.37M+9.4%2013$428.13M+15.9%2012$369.24M+4.0%2011$355.21M+5.3%2010$337.48M+9.5%2009$308.17M—Other metrics: RevenueCost of RevenueOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share